Liu-fang Gu

发表

Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia

Liu-fang Gu, Wang-gang Zhang, Fangxia Wang, 2011, Journal of Cancer Research and Clinical Oncology.

Effect of granulocyte colony-stimulating factor priming combined with low-dose cytarabine and homoharringtonine in higher risk myelodysplastic syndrome patients.

Liu-fang Gu, Wang-gang Zhang, Fangxia Wang, 2016, Leukemia research.

Quantitative assessment of MLAA-34 expression in diagnosis and prognosis of acute monocytic leukemia

Xin Meng, Wanggang Zhang, Liu-fang Gu, 2011, Cancer Immunology, Immunotherapy.

Management of cytokine release syndrome related to CAR-T cell therapy

B. Lei, Wanggang Zhang, Liu-fang Gu, 2019, Frontiers of Medicine.

Durable remissions with BCMA-specific chimeric antigen receptor (CAR)-modified T cells in patients with refractory/relapsed multiple myeloma.

B. Lei, Wanggang Zhang, Liu-fang Gu, 2017 .

Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study

B. Lei, Wanggang Zhang, Liu-fang Gu, 2016, Medical science monitor : international medical journal of experimental and clinical research.

Expression profile analysis of long non‐coding RNA in acute myeloid leukemia by microarray and bioinformatics

Tian Liu, Liu-fang Gu, Fangxia Wang, 2018, Cancer science.

Inhibition of WNT7A-β-catenin signaling pathway sensitizes oral squamous cell carcinoma to cisplatin.

Liu-fang Gu, Jiangang Tian, Xiaoguang Cui, 2018, International journal of clinical and experimental pathology.

Prediction and identification of HLA-A*0201-restricted epitopes from leukemia-associated protein MLAA-22 which elicit cytotoxic T lymphocytes

Wanggang Zhang, Jing Li, Liu-fang Gu, 2014, Medical Oncology.

mRNA expression of the XAGE-1 gene in human acute leukemia

Yuqiang Ji, Wanggang Zhang, Liu-fang Gu, 2010, International journal of hematology.

Investigation of a novel biomarker, neuropilin-1, and its application for poor prognosis in acute myeloid leukemia patients

Liu-fang Gu, Chengliang Li, Jianqiang Zhao, 2014, Tumor Biology.

Pellino-1 Protects Periodontal Ligament Stem Cells Against H2O2-Induced Apoptosis via Activation of NF-κB Signaling

Xueliang Wang, Liu-fang Gu, Ruizhe Huang, 2018, Molecular Biotechnology.

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Saijuan Chen, Hua Jiang, Jian-yong Li, 2022, Journal of Hematology & Oncology.

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

B. Lei, Y. Geng, Zong-fang Li, 2018, Journal of Hematology & Oncology.

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China

B. Lei, Liu-fang Gu, Fangxia Wang, 2020 .

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

Zong-fang Li, B. Lei, Y. Geng, 2018, Blood.

The expression and functional characterization associated with cell apoptosis and proteomic analysis of the novel gene MLAA-34 in U937 cells.

Wen-juan Zhang, Liu-fang Gu, Xing-mei Cao, 2013, Oncology reports.

Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

B. Lei, Y. Geng, Zong-fang Li, 2019, Blood.

Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study

B. Lei, Wanggang Zhang, Liu-fang Gu, 2016, OncoTargets and therapy.

Effects of CpG oligodeoxynucleotides on the differentiation of Treg/Th17 cells.

B. Lei, Yuqiang Ji, Wanggang Zhang, 2021, Molecular immunology.

Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report

Liu-fang Gu, Fangxia Wang, Xing-mei Cao, 2022, Journal of Medical Case Reports.